Leo Pharma partners with Vipergen on dermatology drug discovery
The two firms hope to find new treatments for dermatological diseases using Vipergen’s drug discovery platform.
by andreas lønstrup, translated by daniel pedersen
Dermatology firm Leo Pharma has entered a partnership with Danish firm Vipergen, which provides small molecule drug discovery services based on DNA-encoded library (DEL) technologies, according to a press release.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
